CG Oncology, Inc. (CGON)
64.28
-1.58
(-2.40%)
USD |
NASDAQ |
Mar 20, 13:17
CG Oncology EPS Diluted (Quarterly) : -0.5157 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 0.0054 |
| MannKind Corp. | -0.0519 |
| Madrigal Pharmaceuticals, Inc. | -2.566 |
| Solid Biosciences, Inc. | -0.4848 |
| Arcus Biosciences, Inc. | -0.8945 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -41.31M |
| Revenue (Quarterly) | 2.322M |
| Total Expenses (Quarterly) | 43.63M |
| Enterprise Value | 4.707B |
| Gross Profit Margin (Quarterly) | -34.32% |
| Profit Margin (Quarterly) | -1.78K% |
| Earnings Yield | -3.24% |
| Normalized Earnings Yield | -3.239 |